UA99495C2 - Изольованный цирковирус свиней, композиции и способы для иммунизации свиней против цирковируса свиней - Google Patents

Изольованный цирковирус свиней, композиции и способы для иммунизации свиней против цирковируса свиней

Info

Publication number
UA99495C2
UA99495C2 UAA201007554A UAA201007554A UA99495C2 UA 99495 C2 UA99495 C2 UA 99495C2 UA A201007554 A UAA201007554 A UA A201007554A UA A201007554 A UAA201007554 A UA A201007554A UA 99495 C2 UA99495 C2 UA 99495C2
Authority
UA
Ukraine
Prior art keywords
hog
circovirus
isolated
pmws
immunization against
Prior art date
Application number
UAA201007554A
Other languages
English (en)
Ukrainian (uk)
Inventor
Стивен Циту Ву
Original Assignee
Вайет Ллк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40436491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA99495(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Вайет Ллк filed Critical Вайет Ллк
Publication of UA99495C2 publication Critical patent/UA99495C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Изобретение относится к изолированному цирковирусу свиней, геномная последовательность которого соответствует нуклеотидной последовательности SEQ ID NO: 1 или 2, к иммуногенной композиции, которая включает указанный изолированный цирковирус свиней и дополнительно как минимум один другой микроорганизм или антиген, полученный из указанного микроорганизма, способу иммунизации свиней против вирусной инфекции или мультисистемного синдрома истощения после отлучения (PMWS), или для предотвращения мультисистемного синдрома истощения после отлучения (PMWS) у свиней, вызванного штаммом PCV2 , путем введения свинье эффективного количества указанной иммуногенной композиции, к способу определения, имеет ли свинья мультисистемный синдром истощения после отлучения (PMWS) или имеет риск его развития.
UAA201007554A 2007-12-21 2008-12-18 Изольованный цирковирус свиней, композиции и способы для иммунизации свиней против цирковируса свиней UA99495C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1589407P 2007-12-21 2007-12-21

Publications (1)

Publication Number Publication Date
UA99495C2 true UA99495C2 (ru) 2012-08-27

Family

ID=40436491

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201007554A UA99495C2 (ru) 2007-12-21 2008-12-18 Изольованный цирковирус свиней, композиции и способы для иммунизации свиней против цирковируса свиней

Country Status (16)

Country Link
US (2) US20090162398A1 (ru)
EP (1) EP2225367A1 (ru)
JP (2) JP2011507522A (ru)
KR (1) KR20100094587A (ru)
CN (1) CN101932700A (ru)
AR (1) AR069882A1 (ru)
AU (1) AU2008343172B2 (ru)
BR (1) BRPI0821286A8 (ru)
CA (1) CA2710247C (ru)
CL (1) CL2008003813A1 (ru)
CO (1) CO6290791A2 (ru)
ME (1) ME01156B (ru)
NZ (1) NZ586238A (ru)
RU (1) RU2493254C9 (ru)
UA (1) UA99495C2 (ru)
WO (1) WO2009085912A1 (ru)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
JP2013507944A (ja) * 2009-10-22 2013-03-07 ウニヴェルシテート・ライプツィヒ 汎血球減少症罹患仔ウシにおけるサーコウイルス（ｃｉｒｃｏｖｉｒｕｓ）の特定
US20120100168A1 (en) * 2010-01-25 2012-04-26 Blood Systems, Inc. Cyclovirus and methods of use
HUE047972T2 (hu) 2010-03-16 2020-05-28 Virginia Tech Intellectual Properties Inc Gyengített, élõ kiméra sertés cirkovírus vakcina
US9932372B2 (en) * 2010-07-08 2018-04-03 United Biomedical, Inc. Designer peptide-based PCV2 vaccine
CN101920012B (zh) * 2010-07-22 2012-12-12 普莱柯生物工程股份有限公司 利用家蚕生物反应器生产猪圆环病毒2型重组衣壳蛋白亚单位疫苗的方法及其产品
KR101030792B1 (ko) * 2010-09-16 2011-04-27 주식회사 코미팜 돼지 써코바이러스２(ｐｃｖ２) 유전자의 표면발현용 벡터 및 이로 형질전환된 살모넬라 백신 균주
CN102199571B (zh) * 2011-04-06 2013-07-31 华中农业大学 一种表达猪2型圆环病毒orf2基因片段的重组支气管败血波氏杆菌株、疫苗及应用
CN102988978B (zh) * 2011-08-01 2016-02-03 普莱柯生物工程股份有限公司 含有猪圆环病毒2型抗原与副猪嗜血杆菌抗原的疫苗组合物及其制备方法与应用
HUP1100470A2 (en) 2011-08-30 2013-03-28 Mezoegazdasagi Biotechnologiai Kutatokoezpont Nanoparticle-based veterinary vaccine
EP2564869A1 (en) 2011-09-02 2013-03-06 Ceva Sante Animale Synthetic capsid proteins and uses thereof
CN103083655B (zh) * 2011-11-02 2015-08-26 普莱柯生物工程股份有限公司 预防和治疗猪圆环病毒2型、副猪嗜血杆菌和猪肺炎支原体感染的疫苗组合物及其制备方法
CN103033622B (zh) * 2011-12-26 2015-03-25 武汉中博生物股份有限公司 猪圆环病毒2型elisa抗原检测试剂盒及其制备方法和其应用
CN102517331A (zh) * 2011-12-26 2012-06-27 武汉中博生物股份有限公司 一种猪圆环病毒2型亚单位疫苗及其制备方法和其应用
US9474692B2 (en) 2012-01-13 2016-10-25 Boehringer Ingelheim Vetmedica Gmbh Kit for the preparation of a vaccinating agent
US9982239B2 (en) 2012-06-12 2018-05-29 Alternative Gene Expression S.L. Baculoviral DNA elements for the expression of recombinant proteins in a host cell
BR112015003074A2 (pt) 2012-08-17 2017-07-04 Intervet Int Bv composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético.
CN102824634B (zh) * 2012-09-14 2014-03-19 范红结 表达猪圆环病毒2型Cap蛋白的重组猪痘病毒载体疫苗及其制备方法
CN103920146A (zh) * 2013-01-14 2014-07-16 普莱柯生物工程股份有限公司 猪圆环病毒ⅱ型与猪伪狂犬病二联疫苗及其制备方法和应用
BR102013001893B1 (pt) * 2013-01-25 2022-01-25 Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig Antígenos recombinantes do porcine circovirus 2 (pcv-2) para formulações vacinais, kit de diagnóstico e uso
EP2789346A1 (en) 2013-04-11 2014-10-15 CEVA Santé Animale SA Fusion polypeptides and vaccines
CN103275938B (zh) * 2013-05-07 2015-02-25 上海市农业科学院 猪圆环病毒弱毒疫苗株的制备方法
EP2994162B1 (en) 2013-05-08 2021-04-07 Pharmgate Biologics Inc. Vaccine for pcv2 and mycoplasma
HUE060972T2 (hu) 2013-08-23 2023-05-28 Boehringer Ingelheim Animal Health Usa Inc 2-es típusú sertés cirkovírus (PCV) alegység vakcina
CA2925281C (en) * 2013-09-25 2022-05-03 Zoetis Services Llc Pcv2b divergent vaccine composition and methods of use
ES2778425T3 (es) 2013-10-02 2020-08-10 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
CN104250640A (zh) * 2014-08-22 2014-12-31 普莱柯生物工程股份有限公司 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用
CN105709220B (zh) * 2014-12-03 2020-03-31 普莱柯生物工程股份有限公司 用于猪圆环病毒与猪流感的疫苗组合物及制备方法和应用
EP3034609A1 (en) 2014-12-19 2016-06-22 Ceva Sante Animale Recombinant swinepox virus and vaccines
CN104984335A (zh) * 2015-07-14 2015-10-21 浙江诺倍威生物技术有限公司 猪圆环病毒双亚型orf2共表达载体构建及疫苗制备
RU2744193C2 (ru) * 2015-10-16 2021-03-03 Канзас Стейт Юниверсити Рисерч Фаундейшн Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения
AU2016380864B2 (en) * 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
CN105785037B (zh) * 2016-03-30 2017-09-19 中国农业科学院兰州兽医研究所 猪圆环病毒2型抗体快速检测层析试纸条及制备方法
EP3254692A1 (en) 2016-06-10 2017-12-13 Ceva Sante Animale Multivalent recombinant spv
CN106435016B (zh) * 2016-08-30 2019-07-26 中国农业科学院兰州兽医研究所 一种快速显色一步法检测猪圆环病毒2型的lamp试剂盒
CN107937354A (zh) * 2017-11-10 2018-04-20 南京天邦生物科技有限公司 2型猪圆环病毒及其应用
US20200390878A1 (en) 2017-12-08 2020-12-17 Ceva Sante Animale Recombinant swinepox virus and vaccines
KR102133632B1 (ko) * 2018-03-29 2020-07-13 충남대학교산학협력단 재조합 돼지 써코바이러스 및 이를 포함하는 돼지 써코바이러스 감염 질환의 예방용 백신 조성물
CN112292149A (zh) 2018-06-11 2021-01-29 法国诗华大药厂 针对猪圆环病毒的疫苗接种
CN109381696A (zh) * 2018-08-27 2019-02-26 长沙创西生物科技有限公司 一种用于防治猪圆环病毒病的缓释微囊的制备方法
CN111088396A (zh) * 2019-11-14 2020-05-01 河南科技学院 一种同时检测副猪嗜血杆菌、猪细小病毒、猪圆环病毒2型的三重实时荧光pcr方法
RU2747468C1 (ru) * 2020-06-23 2021-05-05 Федеральное Казенное Предприятие "Щелковский Биокомбинат" Способ получения вакцины против цирковируса свиней (варианты)
CN113907044A (zh) * 2021-11-09 2022-01-11 福建省连江县刘氏兔业养殖场 一种抗病猪品系的培育方法及其应用
CN115820840A (zh) * 2022-11-23 2023-03-21 武汉轻工大学 一种副猪嗜血杆菌感染后引起仔猪免疫抑制的分子标记物
US20250332242A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use
US20250332243A1 (en) 2024-04-30 2025-10-30 Zoetis Services Llc Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247080A (en) * 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US5238662A (en) * 1987-07-31 1993-08-24 Chevron Research Company Processes for recovering precious metals
US5147966A (en) * 1990-07-31 1992-09-15 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Polyimide molding powder, coating, adhesive and matrix resin
UA78180C2 (ru) * 1997-10-03 2007-03-15 Меріаль Кольцевой вирус свиньи, вакцины и диагностические реагенты
FR2769322B1 (fr) * 1997-10-03 2002-03-08 Merial Sas Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
FR2781159B1 (fr) * 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US20040062775A1 (en) * 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
WO1999045956A1 (en) * 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
MY146518A (en) * 2001-03-27 2012-08-15 Univ Saskatchewan Methods to culture circovirus.
US20030096377A1 (en) * 2001-06-28 2003-05-22 Virginia Tech Intellectual Properties, Inc. Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CA2635430A1 (en) * 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs

Also Published As

Publication number Publication date
US20110305725A1 (en) 2011-12-15
CA2710247A1 (en) 2009-07-09
RU2010124791A (ru) 2012-01-27
WO2009085912A1 (en) 2009-07-09
AU2008343172A1 (en) 2009-07-09
CO6290791A2 (es) 2011-06-20
JP2011507522A (ja) 2011-03-10
CL2008003813A1 (es) 2009-03-20
RU2493254C9 (ru) 2013-12-20
ME01156B (me) 2013-03-20
US20090162398A1 (en) 2009-06-25
JP2017060473A (ja) 2017-03-30
BRPI0821286A2 (pt) 2014-10-14
RU2493254C2 (ru) 2013-09-20
CA2710247C (en) 2014-02-18
BRPI0821286A8 (pt) 2017-08-15
AU2008343172B2 (en) 2015-02-19
KR20100094587A (ko) 2010-08-26
CN101932700A (zh) 2010-12-29
NZ586238A (en) 2012-10-26
AR069882A1 (es) 2010-02-24
EP2225367A1 (en) 2010-09-08

Similar Documents

Publication Publication Date Title
NZ586238A (en) Methods and compositions for immunizing pigs against porcine circovirus
MY156422A (en) Methods and compositions for live attenuated viruses
MX2009006760A (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedades meningococicas.
GB0712160D0 (en) Methods and compositions in the treatment of procine circoviral infection
JP6824177B2 (ja) 豚流行性下痢ウイルス株及びそれから得られる免疫原性組成物
MXPA05011110A (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de un padecimiento originado por meningococos.
MY150613A (en) Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
EP4368202A3 (en) Attenuated viruses useful for vaccines
MX2009006178A (es) Vacuna contra salmonela.
MX2013010620A (es) Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
SI1954308T1 (sl) Stabilizatorji za liofilizirana cepiva
MX346862B (es) Secuencias consenso de envoltura de vih y método para usar las mismas.
DE602006019629D1 (de) Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
WO2008039408A3 (en) Live bacterial vaccines for viral infection prophylaxis or treatment
NZ593220A (en) Immunostimulatory oligonucleotides
WO2007126816A3 (en) Methods and compositions for vaccination of poultry
EP2574170A4 (en) IMMUNOSTIMULATORY AND VACCINE COMPOSITIONS
BRPI1007721B1 (pt) composição de vacina para uso na indução de uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolado de cdc-9 e cepa de rotavírus isolado de cdc-66
MY144689A (en) Dengue serotype 1 attenuated strain
PH12015501378A1 (en) Porcine parvovirus 5a, methods of use and vaccine
WO2007082734A3 (en) Influenza vaccine
WO2011100489A3 (en) Improved live bacterial vaccine safety
NZ591188A (en) West nile virus vaccine
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
WO2007015783A3 (en) Attenuated strains of flaviviruses , and uses thereof